Geoffroy Bragadir

CEO

30 past transactions

PathoQuest

Venture Round in 2018
PathoQuest SAS, a spin off of Institut Pasteur, is a biotechnology company offering a game changing metagenomics approach to improving the breadth of pathogen detection. The company’s proprietary next generation sequencing (NGS) based testing approach delivers actionable reports to clinicians, biologists and biopharmaceutical quality assurance managers/production managers. PathoQuest’s proprietary sample preparation, and its comprehensive database of pathogens genomic information, enables clinicians and biopharma companies to overcome the current limitation of infectious agent detection. PathoQuest’s Viral Safety testing service, directed towards biopharmaceutical companies, is the company’s first commercial application of its testing approach and has quickly established a revenue stream for the company from several major biopharma companies.

Evercontact

Convertible Note in 2018
Evercontact is an email software startup bringing natural language processing to email and contact management. Evercontact was launched in 2014 by a team of experienced developers and linguistic engineers. Evercontact was acquired by One More Company Inc in August 2016.

Famoco

Series B in 2017
Famoco provides a secure ecosystem allowing organizations to deploy their business applications quickly and seamlessly. Famoco designs corporate-owned devices with zero-street-value, based on a privacy-oriented Android OS for Enterprise, remotely manageable from one SaaS platform. It facilitates the application deployments and secures data capture for mobile payments, public transport, and identity verification (KYC) and mobile workforce management. Organizations can configure device profiles, push apps, track their location and add custom branding from a Famoco MDM. Today, Famoco is expanding worldwide and has deployed more than 250,000 devices in over 35 countries.

Opendatasoft

Series A in 2016
Opendatasoft is a global leader in the democratization of data. It provides an all-in-one SaaS platform that allows all teams to quickly create compelling digital experiences with their data and share them across their internal and external ecosystems. This allows customers to accelerate digital transformation and development, positively transform their operations and establish more transparent relationships with their stakeholders. More than 350 organizations around the world have adopted Opendatasoft's platform. They include large companies such as Schneider Electric, UK Power Networks, SFR, Bloomberg Associates, Veolia and Saint Gobain, government and state departments, and major cities such as Paris, Vancouver, Long Beach, Bristol, Namur and Eindhoven.

BizMeeting

Seed Round in 2016
Bizmeeting is an online booking platform for seminars and professional meetings. They developed two products: an open website for general customers, and a booking platform for recurring clients. They referenced 20,000 places in France (hotels, business and conference centers, more unusual locations like museums, etc.

One More Company

Seed Round in 2016
Senders™ is a contextual intelligence email service offered by One More Company, Inc, the company behind Trackbuster™, which offered the same email untracking features now available as part of Senders. Senders is the latest product from One More Company. It functions like Caller ID for email by providing the recipient more information about the sender right in the email, so it works everywhere, regardless of app, platform, and device. Senders™ is a patent-pending service designed and securely hosted in the US. They are focused on enhancing the email experience for individuals and businesses by helping users filter the messaging signal from the noise and providing relevant information on the fly, in an open way. They provide simple, intuitive services around messaging and the cloud. They are driven by a digital ethics based on consumer control, privacy, and transparency. Their users are their customers and their interests are paramount. Their business model is not based on selling ads, or collecting and selling data. At One More Company, Inc., creating a positive consumer experience is their highest priority, and their raison d’être. Their products are designed to make life easier. They can’t do that without ensuring user privacy and the security of personal information. So, they think about privacy and security from the beginning, and throughout the product design process; in other words, privacy by design. One More Company, Inc is a U.S. corporation founded by seasoned executives with decades of experience in Silicon Valley, at places like Google, Facebook, Twitter, and IBM. It has offices in New York and Paris. Senders™ is a patent-pending service designed and securely hosted in the USA.

Captain Contrat

Seed Round in 2016
Captain Contrat supports the creators and leaders of TPE and PME in legal proceedings. The platform offers online and personalized formalities and legal documents based on the network of lawyers for an affordable price.

Jabmo

Series B in 2015
Jabmo pioneered a whole new approach to account-based marketing with their hyper-aware ABM platform, advertising, and managed services. They are the disruptive vendor in a market where most B2B marketing programs still focus only on known contacts. Their vision, technology, and talent have fueled their rapid growth worldwide. Global manufacturers such as Eaton and BD rely on Jabmo to drive revenue by serving personalized and relevant ads to target accounts throughout the buying cycle. They are specialized in ABM for manufacturers and they are the most international vendor with local support throughout EMEA and USA. With their ABM Platform, their customers see over 2X marketing engagement from target accounts and higher sales win rates.

PathoQuest

Venture Round in 2015
PathoQuest SAS, a spin off of Institut Pasteur, is a biotechnology company offering a game changing metagenomics approach to improving the breadth of pathogen detection. The company’s proprietary next generation sequencing (NGS) based testing approach delivers actionable reports to clinicians, biologists and biopharmaceutical quality assurance managers/production managers. PathoQuest’s proprietary sample preparation, and its comprehensive database of pathogens genomic information, enables clinicians and biopharma companies to overcome the current limitation of infectious agent detection. PathoQuest’s Viral Safety testing service, directed towards biopharmaceutical companies, is the company’s first commercial application of its testing approach and has quickly established a revenue stream for the company from several major biopharma companies.

Famoco

Series A in 2015
Famoco provides a secure ecosystem allowing organizations to deploy their business applications quickly and seamlessly. Famoco designs corporate-owned devices with zero-street-value, based on a privacy-oriented Android OS for Enterprise, remotely manageable from one SaaS platform. It facilitates the application deployments and secures data capture for mobile payments, public transport, and identity verification (KYC) and mobile workforce management. Organizations can configure device profiles, push apps, track their location and add custom branding from a Famoco MDM. Today, Famoco is expanding worldwide and has deployed more than 250,000 devices in over 35 countries.

Opendatasoft

Seed Round in 2015
Opendatasoft is a global leader in the democratization of data. It provides an all-in-one SaaS platform that allows all teams to quickly create compelling digital experiences with their data and share them across their internal and external ecosystems. This allows customers to accelerate digital transformation and development, positively transform their operations and establish more transparent relationships with their stakeholders. More than 350 organizations around the world have adopted Opendatasoft's platform. They include large companies such as Schneider Electric, UK Power Networks, SFR, Bloomberg Associates, Veolia and Saint Gobain, government and state departments, and major cities such as Paris, Vancouver, Long Beach, Bristol, Namur and Eindhoven.

Smallable

Series B in 2015
Smallable is an e-commerce company offering various brands of children’s clothing, furniture, decorations, and toys. It is a family concept-store that provides its clients with more than 800 fashion and home décor designer brands and 30 000+ items including fashion, decoration, furniture, toys, and books. Smallable's variety of top brands includes Bobo Choses, Stella McCartney, Chloé, The Animals Observatory, Hartô, Nobodinoz, and dozens of limited editions.

Evercontact

Convertible Note in 2015
Evercontact is an email software startup bringing natural language processing to email and contact management. Evercontact was launched in 2014 by a team of experienced developers and linguistic engineers. Evercontact was acquired by One More Company Inc in August 2016.

Jabmo

Series A in 2015
Jabmo pioneered a whole new approach to account-based marketing with their hyper-aware ABM platform, advertising, and managed services. They are the disruptive vendor in a market where most B2B marketing programs still focus only on known contacts. Their vision, technology, and talent have fueled their rapid growth worldwide. Global manufacturers such as Eaton and BD rely on Jabmo to drive revenue by serving personalized and relevant ads to target accounts throughout the buying cycle. They are specialized in ABM for manufacturers and they are the most international vendor with local support throughout EMEA and USA. With their ABM Platform, their customers see over 2X marketing engagement from target accounts and higher sales win rates.

Mobeye

Series A in 2015
Mobeye is taking Retail Execution to the next level! Mobeye provide cutting-edge technologies and crowdsourced in-store data collection tools for FMCG Brands & Retailers in Europe, Asia & USA.

TeVolution

Series A in 2014
TeVolution offers a full television bundle (OTT): movies, series, entertainment and digital testrial television (TNT). TeVolution, a French television operator with an enhanced offer for all types of broadband, has established itself in the connected TV market by offering a unique and innovative offer

Famoco

Venture Round in 2013
Famoco provides a secure ecosystem allowing organizations to deploy their business applications quickly and seamlessly. Famoco designs corporate-owned devices with zero-street-value, based on a privacy-oriented Android OS for Enterprise, remotely manageable from one SaaS platform. It facilitates the application deployments and secures data capture for mobile payments, public transport, and identity verification (KYC) and mobile workforce management. Organizations can configure device profiles, push apps, track their location and add custom branding from a Famoco MDM. Today, Famoco is expanding worldwide and has deployed more than 250,000 devices in over 35 countries.

Pixeo

Series B in 2013
Groupe Pixeo, startup lilloise. Expert assurance et éditeur de sites de comparaison d'assurance.

PathoQuest

Series B in 2013
PathoQuest SAS, a spin off of Institut Pasteur, is a biotechnology company offering a game changing metagenomics approach to improving the breadth of pathogen detection. The company’s proprietary next generation sequencing (NGS) based testing approach delivers actionable reports to clinicians, biologists and biopharmaceutical quality assurance managers/production managers. PathoQuest’s proprietary sample preparation, and its comprehensive database of pathogens genomic information, enables clinicians and biopharma companies to overcome the current limitation of infectious agent detection. PathoQuest’s Viral Safety testing service, directed towards biopharmaceutical companies, is the company’s first commercial application of its testing approach and has quickly established a revenue stream for the company from several major biopharma companies.

MerciHenri.com

Venture Round in 2013
MerciHenri.com, which has served over 3 million customers since its inception in 2011, is the only insurance comparison website within the French market whose offering extends beyond price comparisons. It enables customers to filter their search criteria according to their budget and desired level of protection and services, as well as the availability of insurance agents or brokers to provide individually tailored assistance locally. Its website, which receives around 1 million unique visits every month, offers an immediate comparison of more than 80 insurers and lists more than 1,500 insurance brokers, agents and local advisors.

Adamence

Series B in 2011
Established in 2005, Adamence is a pioneer in online jewellery sales. Thanks to its access to and control of goods and manufacturing, Adamence offers a wide product range while remaining competitive on price. The company's growth was historically based on the sale of diamond jewellery. It gradually expanded its offering and now provides a full range of premium jewellery (diamonds, coloured gemstones, pearls, jewellery for men). The website also offers the option for customers to create their own compositions, to obtain fully personalised jewellery.

Anaconda Pharma

Series B in 2010
Anaconda Pharma is a privately held biopharmaceutical company incorporated in November 2003 and operating from lab space within the BioTop incubator at the Pasteur Institute campus in Paris, France.

Pharnext

Series A in 2010
Pharnext is an advanced clinical-stage biopharmaceutical company founded in April 2007 by renowned scientists and entrepreneurs including Professor Daniel Cohen and collaborators, pioneers in modern genomics. The company develops new therapeutics for neurodegenerative diseases - orphan and common – where there are currently no cures and existing therapies available. Pharnext is the pioneer of a new paradigm for the discovery of medicinal drugs: PLEOTHERAPY™. The R&D approach protected by Pharnext systemizes new uses of approved drugs. It is based on network pharmacology utilizing complex and extensive genomic data to identify the thousands of molecules possibly involved in a disease. From this disease molecular network, Pharnext deduces synergistic combinations of drugs already approved but for unrelated indications. These novel therapeutics called PLEODRUG™ are then developed at new optimal doses and under new formulations. They offer several key advantages: efficacy, safety, and intellectual property including several composition of matter patents already granted. The proof of concept of the PLEOTHERAPY approach was obtained with PLEODRUG PXT3003 in Charcot-Marie-Tooth disease type 1A (CMT1A) through positive and consistent Phase 2 and Phase 3 results. PLEODRUG PXT864 generated encouraging Phase 2 data in Alzheimer’s disease. They also plan to develop the same agent in other orphan and common neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis (ALS).

Medelpharm

Venture Round in 2008
Medelpharm is manufactures innovative powder compression devices for research & development experts. MEDELPHARM’s Philosophy is based on the continuous search for innovation in powder compression for research & development experts linked to a sustained strive for excellence in close partnership with our customers. After over 70 years of deep-rooted passion for high precision engineering, MEDELPHARM broke away from the purely mechanical industry and put the design & development of R&D Tablet Presses and tabletting technologies in the focus of its operations. Complete and innovative solutions are ensured by a global team of highly competent professionals in the field of engineering, software development, tabletting technologies & formulation.

EncherExpert

Venture Round in 2008
EncherExpert is a provider of an online shopping platform. The company offers an e-commerce platform which sells luxury goods, decorative items and art objects both online and and in store.

CoSpirit MediaTrack

Venture Round in 2007
CoSpirit MediaTrack is a marketing and communication consulting group that advises clients on the implementation and optimization of their campaigns.

Team Trade

Venture Round in 2007
Team Trade provides financial consultancy & IT services for the financial markets.

Sinequa

Series A in 2006
Sinequa serves both large and complex organizations with the most complete enterprise search, ever. Customers employ our intelligent search platform to connect all content (both text and data), derive meaning, learn from user interactions, and present information in context. This solves content chaos and informs employees through a single, secure interface. They get the knowledge, expertise, and insights needed to make informed decisions and do more, faster. These organizations accelerate innovation, reduce rework, foster collaboration, ensure compliance, and increase productivity. Become Information-Driven™ with Sinequa. For more information visit www.sinequa.com

CONEXANCE MD

Venture Round in 2006
CONEXANCE MD specializing in direct marketing and database shared, MD Conexant developed the first shared database dedicated to distance selling and electronic commerce.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.